DK0758245T3 - Anvendelse af spiramycin ved gastrointestinale sygdomme forårsaget af H. pylori - Google Patents

Anvendelse af spiramycin ved gastrointestinale sygdomme forårsaget af H. pylori

Info

Publication number
DK0758245T3
DK0758245T3 DK95918047T DK95918047T DK0758245T3 DK 0758245 T3 DK0758245 T3 DK 0758245T3 DK 95918047 T DK95918047 T DK 95918047T DK 95918047 T DK95918047 T DK 95918047T DK 0758245 T3 DK0758245 T3 DK 0758245T3
Authority
DK
Denmark
Prior art keywords
spiramycin
pct
pylori
gastrointestinal disorders
disorders caused
Prior art date
Application number
DK95918047T
Other languages
Danish (da)
English (en)
Inventor
Erik T Forfang
Sven-Erik Larssen
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK0758245T3 publication Critical patent/DK0758245T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK95918047T 1994-04-25 1995-04-24 Anvendelse af spiramycin ved gastrointestinale sygdomme forårsaget af H. pylori DK0758245T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9404952A FR2718965B1 (fr) 1994-04-25 1994-04-25 Nouvelle application thérapeutique de la spiramycine.
PCT/FR1995/000533 WO1995028943A1 (fr) 1994-04-25 1995-04-24 UTILISATION DE LA SPIRAMYCINE DANS DES DESORDRES GASTROINTESTINAUX DUS A $i(H. PYROLI)

Publications (1)

Publication Number Publication Date
DK0758245T3 true DK0758245T3 (da) 2003-07-07

Family

ID=9462476

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95918047T DK0758245T3 (da) 1994-04-25 1995-04-24 Anvendelse af spiramycin ved gastrointestinale sygdomme forårsaget af H. pylori

Country Status (16)

Country Link
US (1) US6162792A (ko)
EP (1) EP0758245B1 (ko)
JP (2) JP3937448B2 (ko)
KR (1) KR970702054A (ko)
CN (1) CN1147204A (ko)
AT (1) ATE234619T1 (ko)
AU (1) AU2412795A (ko)
BR (1) BR9507848A (ko)
CA (1) CA2188697A1 (ko)
DE (1) DE69529981T2 (ko)
DK (1) DK0758245T3 (ko)
ES (1) ES2194907T3 (ko)
FR (1) FR2718965B1 (ko)
NO (1) NO311285B1 (ko)
PT (1) PT758245E (ko)
WO (1) WO1995028943A1 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN190017B (ko) 1999-01-25 2003-05-31 Panacea Biotech Ltd
US6576625B2 (en) 2001-03-16 2003-06-10 Panacea Biotic Limited Targeted vesicular constructs for cytoprotection and treatment of H. pylori infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0375068A1 (en) * 1988-12-23 1990-06-27 Gist-Brocades N.V. Combining bismuth compounds and tetracyclines

Also Published As

Publication number Publication date
BR9507848A (pt) 1997-09-16
DE69529981D1 (de) 2003-04-24
JP2007091761A (ja) 2007-04-12
NO964252L (no) 1996-10-07
ATE234619T1 (de) 2003-04-15
DE69529981T2 (de) 2003-12-04
CA2188697A1 (fr) 1995-11-02
CN1147204A (zh) 1997-04-09
JP3937448B2 (ja) 2007-06-27
US6162792A (en) 2000-12-19
KR970702054A (ko) 1997-05-13
NO311285B1 (no) 2001-11-12
EP0758245A1 (fr) 1997-02-19
PT758245E (pt) 2003-08-29
WO1995028943A1 (fr) 1995-11-02
EP0758245B1 (fr) 2003-03-19
FR2718965A1 (fr) 1995-10-27
FR2718965B1 (fr) 1996-05-24
AU2412795A (en) 1995-11-16
JPH09512262A (ja) 1997-12-09
ES2194907T3 (es) 2003-12-01
NO964252D0 (no) 1996-10-07

Similar Documents

Publication Publication Date Title
IS4187A (is) Ný lyfjablanda til inntöku um munn sem inniheldurnýtt magnesíumsalt ómeprasóls, aðferð við framleiðslu hennar og notkun
DE69940769D1 (de) Orale flüssige zusammensetzungen
BG104877A (en) N-substituted anminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
NO993979L (no) FremgangsmÕte for Õ forhindre og forsinke starten pÕ Alzheimer's sykdom og sammensetning derfor
DK0792149T3 (da) Orale præparater indeholdende ondansetron
IL94459A0 (en) Pharmaceutical form and process for the preparation thereof
BR9814923A (pt) Método para tratamento de doença de alzheimer
FI972703A (fi) Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia
IL113450A (en) Process for the preparation of high solubility multicomponent inclusion complexes consisting of an acidic drug a cyclodextrin and a base and the complexes produced thereby
DK1207870T3 (da) Farmaceutiske præparater, der indeholder N-palmitoylethanolamid og anvendelse deraf
DK0748314T3 (da) Tetrasubstituerede imidazolderivater, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf
DK0758245T3 (da) Anvendelse af spiramycin ved gastrointestinale sygdomme forårsaget af H. pylori
HUT77868A (hu) Imidazopiridin-azolidinonok, ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk és eljárás előállításukra
UA66932C2 (en) Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine
MX9802809A (es) Ureasa para el tratamiento de infecciones de helicobacter pylori.
SE9404438D0 (sv) New process
RU98114982A (ru) Состав, содержащий диосгенин
IL117734A0 (en) Beta-carbolines and pharmaceutical compositions containing them